Scarica l'app Stockscreener
68.11
0.58%
0.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MIRM Giù?
Forum
Previsione
Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie
Responsive Playbooks and the MIRM Inflection - news.stocktradersdaily.com
Mirum to present new data on liver disease therapies at AASLD meeting - Investing.com Australia
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD's The Liver Meeting - Investing News Network
Mirum to present new data on liver disease therapies at AASLD meeting By Investing.com - Investing.com South Africa
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting® - Business Wire
Is Mirum Pharmaceuticals Inc. stock overvalued by current metrics2025 Short Interest & Verified Technical Signals - newser.com
Mirum Pharmaceuticals engages at NASPGHAN 2025 Annual Meeting - Traders Union
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2025 Earnings Call Transcript - Insider Monkey
Published on: 2025-11-06 04:51:32 - newser.com
Why Mirum Pharmaceuticals Inc. stock is rated strong buy2025 Technical Overview & Consistent Profit Focused Trading Strategies - fcp.pa.gov.br
Is Mirum Pharmaceuticals Inc. (08D) stock worth buying before Fed action2025 Momentum Check & Weekly Breakout Watchlists - newser.com
Will Mirum Pharmaceuticals Inc. stock outperform tech sector in 2025Market Sentiment Summary & Risk Controlled Stock Alerts - fcp.pa.gov.br
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Mirum Pharmaceuticals (MIRM): Discounted Valuation Reinforces Bullish Narrative on Profit Breakthrough Potential - Yahoo Finance
Citizens Maintains Mirum Pharmaceuticals (MIRM) Market Outperform Recommendation - Nasdaq
MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened - sharewise.com
Will Mirum Pharmaceuticals Inc. stock gain from government policies2025 Institutional Moves & Community Consensus Stock Picks - fcp.pa.gov.br
Mirum Pharmaceuticals (MIRM) Projected to Post Earnings on Tuesday - MarketBeat
Will breakout in Mirum Pharmaceuticals Inc. lead to full recovery2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
What Analysts Are Saying About Mirum Pharmaceuticals Stock - Benzinga
Mirum Pharmaceuticals stock price target raised to $95 by Citizens - Investing.com Canada
Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiplesJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - newser.com
Why Mirum Pharmaceuticals Inc. stock remains undervaluedTrend Reversal & Reliable Entry Point Trade Alerts - newser.com
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Mirum Pharmaceuticals Inc (MIRM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Mirum Pharmaceuticals Reports Strong Q3 2025 Growth - TipRanks
Decoding Mirum Pharmaceuticals Inc (MIRM): A Strategic SWOT Insi - GuruFocus
Mirum Pharmaceuticals earnings beat by $0.20, revenue topped estimates - Investing.com Canada
Earnings Call Summary | Mirum Pharmaceuticals(MIRM.US) Q3 2025 Earnings Conference - 富途牛牛
How to build a custom watchlist for Mirum Pharmaceuticals Inc.Earnings Trend Report & Technical Buy Zone Confirmation - newser.com
Earnings call transcript: Mirum Pharmaceuticals reports Q3 2025 earnings beat By Investing.com - Investing.com Nigeria
Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Investing News Network
(MIRM) Mirum Pharmaceuticals Expects Full Year 2025 Revenue Range $500 Million$510 Million, vs. FactSet Est of $506.4 Million - MarketScreener
Earnings call transcript: Mirum Pharmaceuticals reports Q3 2025 earnings beat - Investing.com
Mirum Pharmaceuticals Lifts Guidance After LIVMARLI Sales Surge - Finimize
Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance UK
Mirum Pharmaceuticals Inc (MIRM) Q3 2025 Earnings: EPS of $0.06 - GuruFocus
Earnings Flash (MIRM) Mirum Pharmaceuticals, Inc. Reports Q3 Revenue $133.0M, vs. FactSet Est of $130.5M - MarketScreener
Mirum Pharmaceuticals, Inc. Revises Revenue Guidance for the Year 2025 - MarketScreener
[10-Q] Mirum Pharmaceuticals, Inc. Quarterly Earnings Report | MIRM SEC FilingForm 10-Q - Stock Titan
Mirum Pharmaceuticals Q3 revenue rises on LIVMARLI sales growth - MarketScreener
[8-K] Mirum Pharmaceuticals, Inc. Reports Material Event | MIRM SEC FilingForm 8-K - Stock Titan
Mirum Pharmaceuticals Q3 2025 Earnings Preview - MSN
How currency fluctuations impact Mirum Pharmaceuticals Inc. stock2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
Will Mirum Pharmaceuticals Inc. see short term momentumMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Mirum Pharmaceuticals to Participate in Upcoming November 2025 Investor Conferences - BioSpace
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Investing News Network
Why analysts remain bullish on Mirum Pharmaceuticals Inc. stockAnalyst Upgrade & Smart Allocation Stock Tips - newser.com
Is it time to cut losses on Mirum Pharmaceuticals Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):